Oncologists Risk Self-Referral Violations Over Medicare Mail-Order Drug Rule New interpretation of Stark law excludes distribution of oral oncology drugs by mail Feb 12, 2024
No Relief From Drug Shortages; New Lymphedema Guideline; A 'Good' Patient No More News, features, and commentary about cancer-related issues Feb 09, 2024
Senators Thrash Pharma CEOs for Pricing Drugs Higher in the U.S. Sen. Bernie Sanders blamed "corrupt" system, well-paid lobbyists Feb 09, 2024
Hyperbaric Oxygen Therapy Shows Some Benefit After Breast Cancer Irradiation However, most women declined the therapy in this study Feb 08, 2024
Mixed Results in Advanced Gastric/GEJ Cancer With Add-On Fruquintinib Significant improvement in PFS, but not OS, versus chemo alone in the second-line setting Feb 07, 2024
Pulled Myeloma Drug May Have a Role in Treating the Disease After All Belantamab mafodotin boosts PFS by nearly 2 years when combined with bortezomib, dexamethasone Feb 07, 2024
Smokers Who Quit and Stick With It See Greatest Reduction in Cancer Risk Cessation at any age proved helpful for lowering cancer risk Feb 06, 2024
Smoking Tied to Increased Mortality From Early-Stage Melanoma Association only see among current smokers, however Feb 06, 2024
Patients and Doctors Push Back Against the Harsh Side Effects of Cancer Drugs "If the patients are not taking the drug, then it's not going to work" Feb 06, 2024
King Charles' Health History; Supreme Court to Weigh COVID Misinfo; Toby Keith Dies Health news and commentary from around the Web gathered by staff Feb 06, 2024
All-Oral Therapy Promising in Higher-Risk MDS, CMML In small trial, overall response rate was 95% Feb 05, 2024
Health Effects of Diabetes Remission; High-Deductible Plans for Cancer Patients Also in TTHealthWatch: USPSTF weighs in on screening for language disorders or delays in kids Feb 03, 2024 podcast
A Win for Trabectedin in High-Grade Myxoid Liposarcoma? Statistics support noninferiority versus more toxic chemotherapy, but results far from definitive Feb 02, 2024
Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer News, features, and commentary about cancer-related issues Feb 02, 2024
Improved Fitness May Reduce Prostate Cancer Risk Observational study finds reduced incidence in men who increased their cardiorespiratory fitness Feb 01, 2024
Camp Lejeune Water Contamination Tied to a Range of Cancers, CDC Study Says Health risks now more firmly established, but study falls short of being definitive Feb 01, 2024
Pushback on Rule for Surgical Lymph Node Sampling During Lung Resection Surgeons debate the right standard for lymph node dissection in lung cancer Jan 31, 2024
Sequential Therapy Boosts Survival in Metastatic Pancreatic Cancer Phase II study shows a 32% reduced risk of death compared with standard treatment Jan 31, 2024
Shannen Doherty's 'Miracle Treatment'; Adult 'Diaper Spa'? Israel Raids Hospital Health news and commentary from around the Web gathered by staff Jan 31, 2024
Most Immunocompromised Patients Clear Omicron Infections B-cell malignancies, B-cell treatments associated with longer duration of infection Jan 30, 2024
Peripheral IV Access for Chemo Better Than Central Lines in Testicular Cancer? Retrospective study suggests the technique results in fewer complications, thrombotic events Jan 30, 2024
Unfavorable Colon Cancer Trends in Young Adults Seen Across the Pond, Too Rise in predicted CRC mortality among Europeans under 50 may be due to increasing obesity rates Jan 30, 2024
Some 'Choosing Wisely' Recs Protect Older Folks From Low-Value Care Study looked at how three recommendations changed primary care decisions Jan 29, 2024
First-Line Combo for Cisplatin-Ineligible Bladder Cancer Just Misses Positive Result Cabozantinib-pembrolizumab induced responses in 16 of 35 evaluable patients, but needed one more Jan 29, 2024
Science Sleuths Use Tech to Find Fakery and Plagiarism in Published Research These individuals are keeping researchers and science journals on their toes Jan 29, 2024
More Evidence That ARSIs for Prostate Cancer Differ in Cognitive Effects More fatigue, depression, worse reaction time with enzalutamide as compared with abiraterone Jan 29, 2024
A Win and A Loss for Adjuvant ICIs in Clear Cell Renal Cell Carcinoma Pembrolizumab leads to improved OS; single-agent nivolumab fails to impact DFS Jan 28, 2024
Another Prostate Cancer Screening Candidate Outperforms Standard PSA Testing Multiparametric Stockholm3 avoided far more unnecessary biopsies without sacrificing sensitivity Jan 28, 2024
Adjuvant Pembrolizumab Boosts DFS in High-Risk Muscle Invasive Urothelial Cancer Benefit more than double with the immune checkpoint inhibitor compared with observation Jan 28, 2024
Cancer After Weight Loss; How Older Adults Use the Healthcare System Also in TTHealthWatch: PFAS guidelines for clinicians Jan 27, 2024 podcast
When a Revolutionary Cancer Treatment Causes Cancer The potential benefits of CAR T-cell therapies still far outweigh the risks Jan 27, 2024
Cabozantinib Plus Atezolizumab Delays Progression in mCRPC Combination improved PFS versus more hormonal therapy, but control arm questioned Jan 26, 2024
No Cervical Cancer After HPV Vax; Brain Tumor Blood Test; Weight Loss and Cancer News, features, and commentary about cancer-related issues Jan 26, 2024
Olaparib-Abiraterone in Biomarker-Selected mCRPC Tops Each Agent Alone In small first-line trial, PFS more than doubled with combination Jan 26, 2024
Study Supports High-Dose RT, Long-Term ADT as Standard for High-Risk Prostate Cancer OS, PFS, cancer-specific survival all improved, with no increase in toxicity Jan 26, 2024
How Can Cancer Risk Be Cut in Communities Exposed to Toxins? Group outlines plan to bring the latest testing and treatment to medically underserved minorities Jan 25, 2024
Two-Stage Screening Strategy for Ovarian Cancer Continues to Show Progress Large study shows stage shift, high specificity, increasing PPV over 21 years Jan 24, 2024
